Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatics Inks Deal for Biopendium, Chematica Technologies with Schering

NEW YORK, Oct. 17 (GenomeWeb News) - Inpharmatica said today that it has formed a collaboration with German drugmaker Schering to study protein structures in order to prioritize proteins as drug targets. 


Under the deal, Inpharmatica will make available to Schering its Biopendium and Chematica technologies, which include databases with information on protein sequence, structure, and function, as well as information about the ability of particular proteins to serve as drug targets.


Financial terms of the deal were not disclosed.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.